ECC: Ipilimumab Provides 10-Year Survival in Some Melanoma Patients

Patients with advanced melanoma treated with ipilimumab may be able to survive up to 10 years, according to the results of a study presented at the 2013 European Cancer Congress.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news